Partnership Opportunities
At Adnexus, we're not only open to collaboration but are also actively seeking disruptive innovators to join us. We invite pharmaceutical companies, biotech innovators, and research institutions to harness the power of the Sutra AI Platform and drive the next wave of AI-powered healthcare solutions. Together, we can transform possibilities into realities.
Existing Collaborations
We're proud to partner with the best in the business—leading biotechnology firms, cutting-edge AI research groups, and forward-thinking healthcare organizations. These alliances are the backbone of our mission, amplifying the Sutra AI Platform's ability to deliver groundbreaking medical innovations that redefine what's possible.
Success Stories
The Sutra AI Platform isn't just promising—it's delivering. Here's how we're shaping the future of drug discovery:
Sutra AI identified conserved, immutable targets for HIV monoclonal antibodies in record time, slashing discovery timelines from years to weeks. Validated by independent collaborators, these targets are powering Adnexus' HIV pipeline, including ADX-map1 and ADX-pep1, now advancing toward IND submission.
Leveraging Sutra AI, we analyzed over 8 million compounds to discover Trapicolast—a pioneering antimalarial drug targeting the Plasmodium parasite's apicoplast and vesicular trafficking pathways. This dual-action breakthrough, patented and hailed as a game-changer, promises a future where malaria's grip is broken.
During real-time monitoring of viral mutations, Sutra AI identified neutralizable epitopes in 19 viruses, enhancing pandemic preparedness. Our collaboration with partners in India on resistant malaria strains further demonstrates Sutra's unmatched precision.
By acquiring Sanctum Therapeutics, Sutra AI integrated a long-acting HIV capsid inhibitor with our short-acting monoclonal antibodies, creating a potent dual-therapy approach set to disrupt the $58.24 billion HIV market by 2032.
The Sutra AI Platform incorporates AI-driven neural Temporal Fingerprinting technology, a groundbreaking advancement developed within the platform. This innovation harnesses the platform's formidable capabilities to decode complex EEG and ECG signals from the brain and heart, translating them into precise, actionable health insights.
Contact us today
To explore how the Sutra AI Platform can accelerate your mission and deliver results that matter.
How to Collaborate
Ready to revolutionize medicine with us? Whether you're a pharma giant, a biotech startup, or a research powerhouse, our flexible collaboration models—ranging from joint R&D to licensing and co-development—are designed to maximize impact.
Adnexus Biotechnology's platform
Sutra 2025. All Rights Reserved.
Website Designed by:
